Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Business & Regulation


Business & Regulation Business Practice

Words With the Fearless Leader

| Angus Stewart | 6 min read

Where did DNDi come from – and where is it going? We ask the nonprofit organization’s chief for a rundown

Business & Regulation Profession

Demystifying Cancer R&D

| Maryam Mahdi | 5 min read

Clinical trials? Cancer R&D? AstraZeneca’s Matthew Ellis shares his views on the future of pharma.

Business & Regulation Marketing

Patients, Be Not Afraid

| Ben Beckley | 2 min read

How we can begin overcoming patients’ fears and misconceptions of cell and gene therapy

Business & Regulation Digital Technologies

Collaborating for a Cause

| Maryam Mahdi | 6 min read

Can AI help us better understand and define chronic pain?

Business & Regulation Digital Technologies

Making the Most of Big Data

| Devesh Verma, Brian Gibbs | 4 min read

How AI can be leveraged to improve patient acquisition.

Business & Regulation Digital Technologies

Intelligence By Design

| Maryam Mahdi | 13 min read

Explore the potential of AI with industry experts.

Business & Regulation Business Practice

Finding the True Meaning of Disruption

| Noel Maestre

Disruptive technologies are often talked about in pharma circles. But when it comes to AI, what long-term impact will it have?

Business & Regulation Business Practice

A Certain Shade of Green

| Andrew Toher | 5 min read

Pharmaceutical manufacturers burn through huge amounts of energy – so they need sustainable energy strategies.

Business & Regulation COVID-19

VIDEO: From Quality Control to Cold Chain

| Sponsored by Dätwyler

The world wasn’t ready for COVID-19. But if we learn the right lessons, next time next time we’ll do better.

Business & Regulation Trends & Forecasts

How COVID-19 Saved Pfizer’s Revenue

| Stephanie Sutton | 3 min read

Our animated chart illustrates Pfizer’s changing fortunes – and the significant contribution its COVID-19 efforts have made to revenues.


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register